Lam Christina, Wolfe Lynne, Need Anna, Shashi Vandana, Enns Gregory
University of Washington Seattle Children's Hospital Seattle, Washington
National Institutes of Health Bethesda, Maryland
Individuals with -related congenital disorder of deglycosylation (NGLY1-CDDG) typically display a clinical tetrad of developmental delay / intellectual disability in the mild to profound range, hypo- or alacrima, elevated liver transaminases that may spontaneously resolve in childhood, and a complex hyperkinetic movement disorder that can include choreiform, athetoid, dystonic, myoclonic, action tremor, and dysmetric movements. About half of affected individuals will develop clinical seizures. Other findings may include obstructive and/or central sleep apnea, oral motor defects that affect feeding ability, auditory neuropathy, constipation, scoliosis, and peripheral neuropathy.
DIAGNOSIS/TESTING: The diagnosis of NGLY1-CDDG is established in a proband by the identification of biallelic pathogenic variants in on molecular genetic testing. Typical serum screening tests for congenital disorders of glycosylation (i.e., analysis of serum transferrin glycoforms, N and O glycan profiling) will NOT reliably detect NGLY1-CDDG.
Lubricating eye drops and/or bland ointments for hypolacrima; feeding therapy and/or supplemental tube feeding for those with oromotor deficits and feeding difficulties; adequate access to water and a cool environment (including a cooling vest for those who live in hot climates) for hypohydrosis; vitamin D supplementation for those with vitamin D deficiency; evaluation by a developmental pediatrician and supportive therapies for developmental and cognitive issues; standard treatment for hearing loss, sleep apnea, constipation, scoliosis, and seizure disorder; consideration of referral to a hematologist for abnormal hematologic studies; consideration of referral to a gastroenterologist for elevated liver transaminases. Annual follow up by a pediatrician/internist, rehabilitation medicine specialist, ophthalmologist, neurologist, and nutritionist is recommended. Periodic evaluation by a developmental pediatrician, gastroenterologist/hepatologist, and audiologist should be considered. Hot environment in those with hypohydrosis.
NGLY1-CDDG is inherited in an autosomal recessive manner. At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk relatives, prenatal testing for pregnancies at increased risk, and preimplantation genetic testing are possible if the pathogenic variants in the family are known.
患有与去糖基化相关的先天性疾病(NGLY1 - CDDG)的个体通常表现出临床四联征,即轻度至重度的发育迟缓/智力残疾、泪液分泌减少或无泪、儿童期可能自发缓解的肝转氨酶升高,以及一种复杂的运动过度障碍,可包括舞蹈样动作、手足徐动症、张力障碍、肌阵挛、动作性震颤和共济失调性运动。约一半的受影响个体将出现临床癫痫发作。其他发现可能包括阻塞性和/或中枢性睡眠呼吸暂停、影响进食能力的口腔运动缺陷、听觉神经病、便秘、脊柱侧弯和周围神经病。
诊断/检测:通过分子遗传学检测在先证者中鉴定出双等位基因致病性变异来确立NGLY1 - CDDG的诊断。用于先天性糖基化疾病的典型血清筛查试验(即血清转铁蛋白糖型分析、N和O聚糖谱分析)不能可靠地检测出NGLY1 - CDDG。
对于泪液分泌减少,使用润滑眼药水和/或温和眼膏;对于有口腔运动缺陷和进食困难的患者,进行喂养治疗和/或补充管饲;对于少汗症患者,确保充足的饮水和凉爽的环境(对于生活在炎热气候中的患者,包括使用降温背心);对于维生素D缺乏的患者,补充维生素D;由发育儿科医生进行评估并针对发育和认知问题提供支持性治疗;对听力损失、睡眠呼吸暂停、便秘、脊柱侧弯和癫痫症进行标准治疗;对于血液学检查异常的情况,考虑转诊至血液科医生;对于肝转氨酶升高的情况,考虑转诊至胃肠病科医生。建议由儿科医生/内科医生、康复医学专家、眼科医生、神经科医生和营养师进行年度随访。应考虑由发育儿科医生、胃肠病科医生/肝病科医生和听力学家进行定期评估。少汗症患者所处环境应凉爽。
NGLY1 - CDDG以常染色体隐性方式遗传。在受孕时,受影响个体的每个同胞有25%的机会受到影响,50%的机会成为无症状携带者,25%的机会未受影响且不是携带者。如果家族中的致病性变异已知,则可以对有风险的亲属进行携带者检测、对高风险妊娠进行产前检测以及进行植入前基因检测。